Dermatology Clinical Trials
Links shared publicly online about this topic.
- 1,859total visits
Dermatology Clinical Trials
View full resource at rwjms.umdnj.edu
Tags: Dermatology, Acne, Wart, Clinical Trial, Children's Health
Most Recently Shared on July 30, 2009 at 5:13 pm By:
Do you have warts, severe hand eczema; Is your child already facing acne? Volunteers sought for clinical trials http://tinyurl.com/lr2qsd
New male birth control shot is 100% effective and lasts 10 years | Nerve.com
nerve.com — “New birth control 100% effective more men” View full resource at nerve.com
Most Recently Shared on April 12, 2012 at 7:15 pm By:
Paul J. Turek, MD Physician, Doctor, Surgeon, and Urologist
This is called RISUG or the VasalGel contraceptive and is early clinical trials in India. For accuracy, it is a... http://t.co/Gc02ytBe
AIDSmeds - Top Stories : HIV Vaccine Study Offers Up Possible Antibody Protection Clues
aidsmeds.com — “Scientists continued to unravel clues as to why a combination of two preventive HIV vaccines, ALVAC HIV and AIDSVAX B/E, may have worked for some but not others in a large scale clinical trial reported in 2009.” View full resource at aidsmeds.com
Most Recently Shared on April 11, 2012 at 4:47 pm By:
Until There's A Cure Health Organization
#HIV Vaccine Study Offers Up Possible Antibody Protection Clues http://t.co/sn2eWy1q @pozmagazine Join the Conversation
5 Food-Medicines That Could Quite Possibly Save Your Life
greenmedinfo.com — “Natural remedies may exist in your backyard, refrigerator or spice rack. Plenty of scientific research confirms ancient wisdom. Let food be your medicine. The science supports Turmeric, Apples, Garlic, Honey and sunlight for disease prevention and treatment.” View full resource at greenmedinfo.com
Most Recently Shared on April 11, 2012 at 1:39 pm By:
Targacept: Drug missed goal due to analysis error - BusinessWeek
businessweek.com — “Drug developer Targacept Inc. said Tuesday that further analysis showed an experimental asthma treatment failed one one of its goals in a clinical trial, contrary to what the company previously reported.” View full resource at businessweek.com
Most Recently Shared on April 11, 2012 at 5:11 am By:
Drugs and Devices OW OW Health
Targacept: Drug missed goal due to analysis error - BusinessWeek: Targacept: Drug missed goal due to analy... http://t.co/vyiiMVfu #drug
T-Cell Lymphoma Clinic Trials - YouTube
youtube.com — “Our mission is to improve the cure rate of patients with PTCL and reduce treatment-related toxicity by developing novel targeted therapy using rationally des...” View full resource at youtube.com
Most Recently Shared on April 10, 2012 at 11:50 pm By:
Anas Younes, M.D. Doctor, Internist, Oncologist, and Physician
T cell lymphoma Program at MDACC offers innovative clinical trials... http://t.co/Dgc99sKT
Clinical Drug Trials Increasingly More Available for Individuals with Autism
emaxhealth.com — “The US Food and Drug Administration has approved two medicines for treating one symptom of autism spectrum disorders (irritability) but the agency has...” View full resource at emaxhealth.com
Most Recently Shared on April 10, 2012 at 1:35 pm By:
Denise Reynolds RD Nutritionist and Dietitian
Clinical Drug Trials Increasingly More Available for Individuals with Autism: http://t.co/dhtOoUqJ
Canon, MEDIAN to demonstrate LMS clinical application portfolio at ITEM
news-medical.net — “MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, announced today it will demonstrate its Lesion Management Solutions -LMS- clinical application portfolio together with Canon at ITEM, April 13-15, 2012 in Yokohama, Japan.” View full resource at news-medical.net
Most Recently Shared on April 10, 2012 at 11:50 am By:
Lung Cancer News: Canon, MEDIAN to demonstrate LMS clinical application portfolio at ITEM: MEDIAN Technologies, ... http://t.co/CnPDGIyF
Dr. Mesa Discusses the COMFORT Ruxolitinib Trials
onclive.com — “Dr. Ruben Mesa, from Mayo Clinic, Arizona, Discusses the COMFORT Ruxolitinib Trials” View full resource at onclive.com
Most Recently Shared on April 9, 2012 at 9:05 pm By:
OncLive TV: Dr. Ruben Mesa Discusses the COMFORT Ruxolitinib Trials http://t.co/WxzutZEf
Nanoparticle-delivered RNA interference drug stops head and neck cancer growth
phys.org — “(Phys.org) -- A nanoparticle drug delivery vehicle for small interfering RNA molecules (siRNA), that is already being tested in human clinical trials, now shows promise for the treatment of head and neck cancer. Dong Shin, of Emory University, and Mark E. Davis, of the Nanosystems Biology Cancer Center ...” View full resource at phys.org
Most Recently Shared on April 6, 2012 at 2:07 pm By:
Nanoparticle-delivered RNA interference drug stops head and neck cancer growth http://t.co/Sa7qTaiC
Possible clues found to why HIV vaccine showed modest protection, April 4, 2012 News Release - National Institutes of Health (NIH)
nih.gov — “Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online today in the New England Journal of Medicine. Scientists have found that among adults who received the experimental HIV vaccine during the landmark RV144 clinical trial, those who produced relatively high levels of a specific antibody after vaccination were less likely to get infected with the virus than those who did not. The National Institute of Allergy and Inf” View full resource at nih.gov
Most Recently Shared on April 5, 2012 at 12:38 pm By:
News: Possible clues found to why HIV vaccine showed modest protection http://t.co/xPTgxsxq
Belagenpumatucel-L improves survival for patients with stage 3B/4 NSCLC
news-medical.net — “Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:29 am By:
Lung Cancer News: Belagenpumatucel-L improves survival for patients with stage 3B/4 NSCLC: Long-term follow-up o... http://t.co/f8eeFaIJ
Cutting Malaria By 30 Per Cent Using Combination Drug Treatment
medicalnewstoday.com — “Malaria infections among infants can be cut by up to 30 per cent when antimalarial drugs are given intermittently over a 12 month period, a three-year clinical trial in Papua New Guinea has shown.” View full resource at medicalnewstoday.com
Most Recently Shared on April 4, 2012 at 10:05 am By:
MNT Pediatrics News Pediatrics and Health News
Cutting Malaria By 30 Per Cent Using Combination Drug Treatment http://t.co/v5vrauJx #pediatrics
A.M. Vitals: Some States Move Forward Voluntarily on Health-Insurance Exchanges - Health Blog - WSJ
blogs.wsj.com — “Also: Melanoma rates have increased "dramatically," Mayo Clinic researchers say; Express Scripts closes its acquisition of Medco; and a Novartis COPD treatment met its main goals in three late-stage trials.” View full resource at blogs.wsj.com
Most Recently Shared on April 2, 2012 at 10:34 pm By:
A.M. Vitals: Some States Move Forward Voluntarily on Health-Insurance Exchanges http://t.co/lkTfOB8z
Investigational targeted drug induces responses in aggressive lymphomas, April 2, 2012 News Release - National Institutes of Health (NIH)
nih.gov — “Preliminary results from clinical trials in a subtype of lymphoma show that for a number of patients whose disease was not cured by other treatments, the drug ibrutinib can provide significant anti-cancer responses with modest side effects. These results were presented as part of the opening plenary session at the American Association of Cancer Research (AACR) Annual Meeting 2012 on April 1 by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and coll” View full resource at nih.gov
Most Recently Shared on April 2, 2012 at 1:16 pm By:
News: Investigational targeted drug induces responses in aggressive lymphomas http://t.co/k15ySoFZ
JMIR-Crowdsourced Health Research Studies: An Important Emerging Complement to Clinical Trials in the Public Health Research Ecosystem | Swan | Journal of Medical Internet Research
jmir.org — “Crowdsourced Health Research Studies: An Important Emerging Complement to Clinical Trials in the Public Health Research Ecosystem” View full resource at jmir.org
Most Recently Shared on March 31, 2012 at 1:10 pm By:
Alex Schachinger Health Social Media
Crowdsourced Health Research Studies: An Important Emerging Complement to Clinical Trials in the Public Health Re... http://t.co/Aa3WvmcP
Advertisement
